Objectives: To examine test-retest reliability of the SCAT3 for two consecutive seasons using a large sample of professional male ice hockey players, and to make recommendations for interpreting change on the test.
Introduction
Head and brain injuries, especially concussions, are common and important health issues in collision sports. Ice hockey is a sport characterized by high velocity, rapid changes in direction, and injuries caused by collision with other players, boards, sticks, or pucks. The systematic collection of injury reports from team medical staff shows that the most commonly injured body region in professional male ice hockey is a player's head. 1, 2 The rink side or sideline recognition of sport-related concussion relies on a clinician's evaluation. Injury mechanics, visible signs, reported symptoms, changes in cognitive and physical performance related to concussion, and exclusion of spinal injury are the key points of assessment. International guidelines for sport-related concussion recommend the use of the Sport Concussion Assessment Tool -Third edition (SCAT3) as a supportive instrument in concussion diagnostics. [3] [4] [5] Post-injury SCAT3 scores are best interpreted when compared with either an accurate and reliable individual baseline or to age-and sport-specific normative data. 6, 7 Annual pre-season concussion baseline testing (e.g., computer-based neuropsychological assessment) is common practice in many professional contact sports.
However, there are very few published studies on how often baseline testing should be administered. For example, the SCAT3 is a widely used concussion assessment instrument that has no evidence-based guidelines regarding baseline testing frequencies or intervals. For accurate comparisons between post-injury and baseline performance, it is essential to know how consistent the test-retest results are (i.e. the reliability and stability of the baseline SCAT3 assessment over time). One factor that could influence reliability is learning effect. It is not known if SCAT3 performance is improved by learning when repeatedly done, and if so how long this learning effect lasts. 4 The purpose of this study was to examine the long-term test-retest reliability of SCAT3 assessments in a realistic clinical setting to better understanding normal variation of the scores. We also aimed to describe if there is a significant difference between intra-and interrater reliability and whether the common practice of administering SCAT3 baseline on an annual basis is an ideal time frame or not. Suggestions for interpreting change on the SCAT3
are offered.
Methods
This study is a part of a larger research project that strives to translate international recommendations regarding diagnosis and management of concussions into practice in Foundation. There was no involvement with any commercial sponsor for this study regarding the study design; the collection, analysis, and interpretation of data; the writing of the report;
or the decision to submit the paper for publication. In an effort to replicate how the SCAT3 assessment is given clinically, every player was tested individually, at least ten minutes after physical exertion, by the teams' current medical staff, who were trained to administer SCAT3 in accordance with the SCAT3 instructions in The descriptive statistics and test-retest correlations for the SCAT3 components in two consecutive seasons are presented in Table 1 . In general, at the group level, most of the SCAT3 mean baseline scores remained stable within the one-year interval. The test-retest correlations, however, were uniformly low, with 8/11 scores having a Spearman coefficient of 0.3 or lower. We have previously published normative reference values for the SCAT3 components. 8 Those normative reference values were based on the pre-season SCAT3 test results of season 2013-2014 (n=304 athletes), and they are reprinted in Table 2 . The percentages of the players who were categorized in the same normative classification range in both preseason baseline tests are presented in Table 3 . As seen in column two, most of the players scored in the same normative classification range at both test and retest, and the large majority scored either in the same classification or a higher classification. (worsening) of two or more symptoms at retest occurred in 14.7% of players, and an increase of three or more symptoms occurred in only 10%. As seen in Figure 3 , a total symptom severity score that increases (worsens) by three or more points occurred in 14.1% of athletes, and an increase by five or more points occurred in only 8.8%. As seen in Figure 4 , worsening of two or more points on the SAC occurs in 15.5% of professional athletes, and worsening of three or more points occurs in only 7.2%. As seen in Figure 5 , a worsening on the M-BESS (i.e., an increase in raw scores) by two or more points occurred in 16.7% of players, and a worsening by three or more points was uncommon, occurring in only 8.6% of players. As seen in Table 6 , performing the Tandem Gait test more slowly, by three or more seconds, occurred in 18.2% of the players. Performing four or more seconds slower was uncommon, occurring in only 6.8% of players.
Discussion
This large-scale study of the one-year test-retest reliability of the SCAT3 revealed several important findings for researchers and clinicians. First, the test-retest reliabilities of each component were uniformly low and mostly considered weak according to conventional standards for interpreting stability of human performance tests (see Table 1 important for the test to have adequate reliability and validity for the intended purpose and with the specific clinical population with which it is being used. 9 The problems with reliability, illustrated in this study, are partially mitigated by having normative reference values (Table 2) Nearly equal number of athletes showed improvement and declines over the test-retest interval for the Symptom score, Symptom Severity score, and Tandem Gait; in contrast, performance on the SAC and M-BESS was more likely to improve on the second baseline test. Third, there was no statistically significant difference related to whether the SCAT3 was administered by the same or a different examiner. Fourth, there were no differences in testretest difference scores in those who sustained a concussion between the two baseline assessments and those who did not. Finally, most players (i.e., 71-92%) obtained scores that were in the same normative classification range at both test and retest, based on the norms published by Hanninen and colleagues 8 . Moreover, retest scores were in the same or better normative classification range in 86-96% of athletes. This means that when an athlete is tested a second time, it is very likely that his score will be similar to or better than it was previously.
The information presented in Figures 1-6 is very useful for clinicians and researchers who want to better understand the natural distribution of test-retest difference scores on the SCAT3. This information can also be used to determine an unusual amount of change (i.e., worsening or improving) in SCAT3 performance in Finnish professional ice hockey players.
Based on the current results, 10% or fewer of the athletes showed the following worsening of SCAT3 retest scores: an increase of three or more points on the Symptoms Score, an increase of five or more points on the Symptom Severity score, a worsening of three or more points on the SAC, an increase of three or more error points on the M-BESS, or an increase of four or more seconds on the Tandem Gait. Clinicians should note that professional hockey players perform perfectly or nearly perfectly on the Coordination test and the double-leg stance of the M-BESS, so errors on those tests should be considered abnormal. Clinicians can use the normative classification ranges in Table 2 in combination with these change scores. For example, as seen in Table 2 , an increase of three symptoms or five points on symptom severity will usually result in a worsening in the normative classification, too. This study design was implemented in practical everyday life of professional ice hockey teams in order to maximize the generalizability and the applicability of the results. For this reason, we did not use independent external examiners. Additionally, we explored individual baseline performance changes and not only group level statistics. The strength of our study was the large sample size and the pragmatic study design.
There are several limitations to this study. The athletes' medical history was based on the SCAT3 form and therefore some relevant disease/injury history (e.g., lower limb injuries, sleep history) was not included. The information on previous concussions was solely based on self-report and it is known that athletes may underestimate their past concussions. 10 The possibility of selection bias in player recruitment exists. Finally, we focused on a very narrow demographic group of professional athletes; additional research should be conducted on other sports, levels, genders, and age cohorts.
Conclusions
The SCAT3 is designed to be used on the day-of-injury and in the initial days following injury. It is not designed to measure post-acute or long-term effects of concussion.
There are no evidence-based guidelines regarding whether or not baseline preseason testing is necessary, and how often to do baseline testing (e.g., yearly or less frequently). More research is needed to determine the optimal frequency of baseline testing with the SCAT3, such as studies comparing reliability over different time periods and studies comparing post-injury scores to baseline scores after varying time intervals. It is reasonable to assume that the best way to interpret SCAT3 scores is a combination of comparing an athlete's post-injury scores to a reliable personal baseline and to quality normative data. However, the SCAT3 has low test-retest reliability, making test-retest comparisons challenging. Careful examination of the natural distributions of difference scores provides clinicians and researchers with useful information on how to interpret change on the test. It is important for clinicians and researchers to appreciate that symptom scores can increase as a result of multiple factors separate from concussion, and some variability in test-retest performance is common on the performance-based measures (i.e., SAC, M-BESS, and Tandem Gait) in uninjured athletes.
Practical Implications
It is important to appreciate that SCAT3 symptom reporting can be affected by several factors separate from concussion, and some variability in the balance and cognition measures is common.
Despite low test-retest reliability of the SCAT3, most players have scores that fall within a similar normative classification range across a one-year test-retest interval. Classification ranges are based on the natural distribution of scores because the distributions were not normal. The goal was to select a below/above average cutoff that corresponded with the 25 th and 75 th percentile ranks, but this usually was not possible given the score distributions. Unusually low/high scores correspond with approximately the 10 th and 90 th percentile ranks, and extremely low/high scores correspond with approximately the 2 nd and 98 th percentile ranks. The classifications are worded differently based on the direction of the scoring for the SCAT3 component. Symptom scores and number of errors on the M-BESS are referred to as high and performance on cognitive testing and tandem gait are referred to as low. The months in reverse were stated correctly by 94.0% (n=265; not included as a row in Table 2 Figure 3 . The distribution of individual test-retest absolute difference scores (Symptom Severity) Note: Athletes who had the exact same score (test-retest difference score = 0), better score, and worse score in the second baseline. A worse score indicates an increase in severity of symptoms reported.
